STC1 and breast cancer: Although the immunostaining of breast cancer lung metastases showed no change in the number of α-SMA-positive cells after STC1 manipulation (Fig. 3A, B), the immunostaining of α-SMA may not reflect the activation of lung fibroblasts because of the extremely abundant fibroblasts in the lungs.